Article ID Journal Published Year Pages File Type
8300378 Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2018 35 Pages PDF
Abstract
In general, our work illustrates that it is the MAX to MYCN ratio that can account for tumour progression and clinical outcome in neuroblastoma and proposes that such a ratio should be considered as an important criterion to the design and development of anti-MYCN therapies.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , , , , , , , , , ,